September 16-17, 2025
Sheraton BostonBoston, MAFinance & Accounting Attendees
Current Attendee Stats Overview
This unique event convenes CFOs, Chief Accountants, Controllers and senior-level financial and accounting professionals representing the spectrum of life sciences organizations in various stages of product lifecycles, from innovative clinical and pre-clinical biotechs through mature commercial-stage bio/pharmaceutical companies.
Job Level Breakdown
53% Controller/Director-Level
31% C-Level/Vice President
11% Manager
5% Accountant/Analyst
Team Attendance
74% Attending with Their Team
3 Colleagues Average Team Size
Current Attending Companies Stats Overview
Company Type
77% Biotechnology
19% Pharmaceutical
4% Medical Device
Pre-Commercial vs. Commercial
58% Pre-Commercial: Pure R&D/Drug Discovery
26% Hybrid: Strong R&D Focus, but also Commercial Products
16% Commercial: Commercial Focus, but Ongoing R&D
Public vs. Private
56% Public Companies
44% Private Companies
Life Sciences Finance & Accounting Industry Professionals Slatted to Attend
CFOs, Chief Accountants, and VPs of Finance & Accounting
As of 8.19.2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |
|
|
|
|
|
|
Controllers, Directors, & Heads of Finance & Accounting
As of 8.19.2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Regulatory Bodies
|
|